Primecap Management
BNTX icon

Primecap Management’s BioNTech BNTX Stock Holding History

Primecap Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351M Sell
3,772,031
-21,680
-0.6% -$2.04M 0.21% 87
2026
Q1 		$337M Sell
3,793,711
-6,300
-0.2% -$647K 0.27% 79
2025
Q4 		$362M Sell
3,800,011
-70,755
-2% -$7.13M 0.27% 76
2025
Q3 		$382M Sell
3,870,766
-130,700
-3% -$14M 0.29% 68
2025
Q2 		$426M Sell
4,001,466
-44,959
-1% -$4.54M 0.34% 67
2025
Q1 		$368M Sell
4,046,425
-249,392
-6% -$27.9M 0.3% 70
2024
Q4 		$490M Sell
4,295,817
-220,701
-5% -$25.2M 0.38% 62
2024
Q3 		$536M Sell
4,516,518
-273,000
-6% -$25.1M 0.39% 59
2024
Q2 		$385M Sell
4,789,518
-18,400
-0.4% -$1.68M 0.28% 69
2024
Q1 		$444M Buy
4,807,918
+44,465
+0.9% +$4.26M 0.33% 66
2023
Q4 		$503M Buy
4,763,453
+131,490
+3% +$13.3M 0.4% 60
2023
Q3 		$503M Sell
4,631,963
-27,890
-0.6% -$3.08M 0.42% 56
2023
Q2 		$503M Buy
4,659,853
+85,590
+2% +$9.63M 0.42% 57
2023
Q1 		$570M Buy
4,574,263
+401,097
+10% +$55.1M 0.5% 53
2022
Q4 		$627M Sell
4,173,166
-21,222
-0.5% -$3.27M 0.57% 48
2022
Q3 		$566M Sell
4,194,388
-6,910
-0.2% -$1.06M 0.55% 51
2022
Q2 		$626M Sell
4,201,298
-40,770
-1% -$6.23M 0.56% 51
2022
Q1 		$724M Buy
4,242,068
+54,950
+1% +$9.23M 0.55% 56
2021
Q4 		$1.08B Sell
4,187,118
-96,240
-2% -$26.4M 0.75% 38
2021
Q3 		$1.17B Sell
4,283,358
-277,400
-6% -$88.2M 0.83% 35
2021
Q2 		$1.02B Sell
4,560,758
-260,960
-5% -$49.2M 0.69% 40
2021
Q1 		$526M Buy
4,821,718
+193,521
+4% +$20.6M 0.37% 73
2020
Q4 		$377M Buy
4,628,197
+502,599
+12% +$49.3M 0.28% 84
2020
Q3 		$286M Buy
4,125,598
+1,352,806
+49% +$97.1M 0.24% 90
2020
Q2 		$185M Buy
2,772,792
+160,675
+6% +$8.02M 0.16% 112
2020
Q1 		$153M Buy
2,612,117
+483,935
+23% +$18.8M 0.15% 112
2019
Q4 		$72.1M Buy
+2,128,182
New +$47.7M 0.05% 154

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Primecap Management's BNTX Position: Q2 2026 in Review

Primecap Management reduced its BioNTech (BNTX) stake by 0.57% in Q2 2026, selling an estimated $2.04M and leaving 3,772,031 shares worth $351M. The position accounts for 0.21% of the portfolio, ranked #87.

Primecap Management first reported a position in BNTX in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.17B in Q3 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Primecap Management held 3,772,031 shares of BioNTech worth $351M as of Q2 2026.
  • Primecap Management sold 21,680 BioNTech shares in Q2 2026, an estimated $2.04M.
  • BioNTech made up 0.21% of Primecap Management's portfolio in Q2 2026, its #87 holding.
  • Primecap Management first reported a position in BioNTech in Q4 2019 and has held it in 27 quarters since.
  • Primecap Management's BioNTech position peaked at $1.17B in Q3 2021.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.